GENERAL MOTORS COMPANY (GM): what the price requires
The current priced-in claim for GENERAL MOTORS COMPANY (GM) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/GM
Headline
| Field | Value |
|---|---|
| Ticker | GM |
| Company | GENERAL MOTORS COMPANY |
| Current price | $76.66/sh |
| Composition | Vehicle, parts, and accessories 87% / Used vehicles 1% / Services and other 3% / Leased vehicle income 4% / Finance charge income 4% / Other income 1% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 1.8% |
| Operating margin today | 5.2% |
| Margin compression implied | -3.4pp |
| Multiple paid | 4x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 11.6% cost of capital with 4% terminal growth over a 5-year stage.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.06σ |
| cohort percentile (of 210 peers) | 2 |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by earnings-power and relative-multiple and growth-DCF value, while asset-based lands below the price. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.04x | 5 | expensive |
| Earnings | 1.23x | 3 | expensive |
| Relative | 0.81x | 3 | justifies |
| Growth | 0.54x | 3 | justifies |
Families that justify the price: Earnings, Relative, Growth Families that call it expensive: Asset
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.0%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $204.16 | 0.38x | yes | FCF base $14.8B, growth -2% (input: historical growth), terminal g 0.5%, WACC 6.0%, 5yr projection |
| DCF Exit Multiple | Growth | $143.09 | 0.54x | yes | Exit EV/EBITDA: 9.9x / 11.9x / 13.9x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $74.47 | 1.03x | yes | P/E 20x (static sector reference · 2026-04), scenarios: 16.9x / 20.0x / 23.1x (bear / base = reference held flat / bull), EV/EBITDA 13x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $29.65 | 2.59x | yes | BV/sh $67.67, ROE (TTM) 4.1%, ke 9.3% |
| Two-Stage Excess Return | Asset | $18.99 | 4.04x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $59.10 | 1.30x | yes | Rev $184.6B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.3x / 0.4x / 0.4x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $79.11 | 0.97x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $11.69B × (1−19%) / WACC 6.0% → EPV (no growth) |
| Residual Income | Asset | $15.29 | 5.01x | yes | BV $67.67 + 5yr PV of (ROE (TTM) 4.1% − Kₑ 9.3%) × BV; BV grows 2.6%/yr |
| Graham Number | Asset | $64.59 | 1.19x | yes | √(22.5 × EPS $2.74 × BVPS $67.67) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $94.15 | 0.81x | yes | EBITDA $14.53B × sector EV/EBITDA 13.0x |
| FCF Yield | Earnings | $62.39 | 1.23x | yes | FCF $14757.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $2.30 | 33.33x | yes | EPS $2.74 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $16.33 | 4.69x | yes | BV $67.67 × (ROIC 1.4% / WACC 6.0%) |
| P/Sales Sector | Relative | $299.07 | 0.26x | yes | Revenue $184.62B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $29.62 | 2.59x | yes | EPS $2.74 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $24.4b |
| Net debt / NOPAT (after-tax) | -3.19x (net cash) |
| Net debt / operating income (pre-tax) | -2.58x (net cash) |
| Share count CAGR (buyback) | -10.9% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- At about $79 the market pays roughly 4x company-wide operating income, a multiple so low it sits below what even a 5%-per-year decline in operating profit would warrant. The stretch in this name is not the growth rate the price needs, it is how briefly the market expects the current earnings to last.
- The balance sheet carries net cash of about $24 billion against essentially no corporate gross debt, and management retired 43 million shares in 2025 under a $2.0 billion accelerated repurchase, shrinking the share count at roughly an 11% annual pace.
Bull Case
Start with the one number that decides the verdict: the multiple on operating income. At roughly $79 the price values the whole company at about 4x operating profit. That is not a demanding figure. It is a multiple that already prices in a sustained decline in earnings, which means the bull case does not need growth heroics, it only needs the current profit stream to hold up longer than the market expects. If operating income merely flattens rather than fades, the price has room to re-rate on multiple alone. That single metric, the operating-income multiple, is the hinge: change it from "earnings will erode quickly" to "earnings will persist" and the entire read flips from cheap-for-a-reason to cheap-and-wrong.
The capital structure backs the patience the thesis requires. The corporate balance sheet shows net cash of about $24 billion with no separately reported corporate gross debt, so the company is not running on borrowed time while it works through its product transition. Management is using that strength to compound per-share value directly: the FY2025 10-K describes increasing its repurchase authorization by $6.0 billion to an aggregate of $6.3 billion and executing a $2.0 billion accelerated share repurchase under which "we received and retired 43 million shares upon settlement of the transactions" (FY2025 10-K, accession 0001467858-26-000013). The prior year retired 29 million shares on the same mechanism. A buyback that removes roughly a tenth of the float each year does the heavy lifting on EPS even if the business itself only treads water.
Recent results show the operating story is not deteriorating the way a 4x multiple implies. In Q1 2026 GM reported adjusted EPS of $3.70 against a Wall Street estimate near $2.62, and it raised full-year 2026 adjusted earnings guidance to a range of roughly $11.50 to $13.50 per share. The electric-vehicle losses that weighed on prior years are shrinking, and the company guided to a $1.0 billion to $1.5 billion benefit from rightsizing EV capacity and running at lower wholesale volumes. The financing arm is also growing rather than fading: GM Financial net sales and revenue reached $17,048 million in FY2025, up from $14,184 million the prior year (FY2025 10-K, accession 0001467858-26-000013), adding a more stable, spread-based earnings layer beneath the cyclical vehicle business.
Bear Case
The bear case starts with a qualitative truth the multiple hides: a 4x operating-income multiple is not just "cheap," it is the market's verdict that these earnings are borrowed from a peak it does not expect to repeat. North American pickup and SUV margins are doing most of the heavy lifting, and that profit pool is exactly the kind that compresses when the cycle turns, incentives climb, and a refreshed competitor lineup arrives. The low multiple is the evidence, not the opener: the opener is that the earnings the price rests on look cyclically full rather than durable.
The asset-based methods make that worry concrete. The two excess-return models, which anchor to book value and the return earned on it, land at roughly $19 and $30 per share against the current $79, because trailing return on equity sits near 4%, well below the cost of equity. In plain terms, the accounting equity is not earning enough to justify a price far above book on a steady-state basis. The price holds up only if you believe forward earnings will be materially better than the recent return on capital suggests, and that is precisely the bet the asset lens refuses to make.
The external pressures are real and largely outside management's control. GM flagged $2.5 billion to $3.5 billion of remaining tariff costs for the year, a direct hit to the same North American profit the bull case leans on, and the one-time $0.5 billion favorable IEEPA tariff adjustment in Q1 will not recur. EV restructuring charges have now topped $8.7 billion since mid-2025, a reminder that the transition has been expensive and that the timing of profitable electric volume keeps slipping. A buyback can flatter EPS through a downturn, but it cannot offset a structural step-down in the truck franchise's earning power, and the split among sell-side analysts, with several firms trimming targets even as others raise them, reflects exactly that unresolved question.
Valuation
The valuation X-ray is most useful here for how violently the methods disagree, and that spread is the signal. Group them by family. The growth-DCF families land far above: the perpetual-growth DCF at about $202 and the exit-multiple DCF at about $145, both built on free cash flow of roughly $14.8 billion. The asset-based excess-return models land far below, at roughly $19 and $30, dragged down by a trailing return on equity near 4%. When the families scatter this widely, no single blended number is honest; the question is which lens fits the business.
The inverted read reconciles them. At today's price the market pays about 4x company-wide operating income at a roughly 16% cost of capital over a five-year stage, a multiple that sits below what even a 5%-per-year operating-profit decline would justify. Against GM's own recent results the near-term pace is within range; the demanding part is duration, how long that earnings stream must persist, not how fast it must grow. Against the sector the multiple sits in the lower half of the peer range.
The balance sheet supports carrying the bet rather than fearing it. Net cash of about $24 billion and a steadily shrinking share count mean the downside is cushioned by liquidity and the upside is amplified by repurchases. The honest caveat is the one the asset methods raise: if the truck-driven profit pool is cyclically full, then today's earnings are the wrong base, and a low multiple on a high base is not the bargain it appears to be.
Catalysts
The next earnings print is the cleanest test of the thesis: GM raised 2026 adjusted EPS guidance to roughly $11.50 to $13.50 after a Q1 beat ($3.70 adjusted versus a $2.62 estimate), so the market will watch whether the company holds or lifts that range as the year progresses. Tariffs are the main swing factor in either direction. GM flagged $2.5 billion to $3.5 billion of remaining tariff costs for the year, and the Supreme Court conclusion that the IEEPA did not authorize certain tariffs already produced a $0.5 billion favorable adjustment in Q1; further legal and policy developments on auto tariffs would move the earnings base directly. The EV reset is a third catalyst: management expects further but smaller restructuring charges in 2026 and guided to a $1.0 billion to $1.5 billion benefit from rightsizing capacity, so each quarter that confirms shrinking EV losses removes a known drag. Capital returns provide a steady background catalyst, with the $6.3 billion aggregate repurchase authorization disclosed in the FY2025 10-K continuing to reduce the share count. Sentiment is split: Citi set a $131 target on June 1, 2026, near the top of the range, while the broad consensus sits closer to $88 to $93, and several firms have trimmed targets, so an in-line or better year would resolve that disagreement in the bulls' favor.
Sources: CNBC, TIKR, MarketBeat, Benzinga
Peer Cohorts (Per Segment, With Filing Citations)
GMNA / GMI (reported)
- F (Ford Motor Co)
- (no filing in the citation store)
- RIVN (Rivian Automotive, Inc. / DE)
- (no filing in the citation store)
- LCID (Lucid Group, Inc.)
- (no filing in the citation store)
GM Financial (reported)
- ALLY (Ally Financial Inc.)
- (no filing in the citation store)
- COF (CAPITAL ONE FINANCIAL CORP)
- (no filing in the citation store)
- SYF (Synchrony Financial)
- (no filing in the citation store)
- OMF (ONEMAIN HOLDINGS, INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.